Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

5. Stockholder's Deficit (Details 3)

5. Stockholder's Deficit (Details 3) (USD $)	Mar. 31, 2013
Option 1
Lower Limit of Range of Exercise Prices	$ 0.50
Upper Limit Range of Exercise Prices	$ 0.59
Number Outstanding	213,750
Weighted Average Exercise Price, options outstanding	$ 0.5
Weighted Average Remaining Contractual Life	9 years 3 months 18 days
Number Exercisable	168,751
Weighted Average Exercise Price, options exercisable	$ 0.5
Weighted Average Remaining Contractual Life Options Exercisable	9 years 3 months 18 days
Option 2
Lower Limit of Range of Exercise Prices	$ 0.60
Upper Limit Range of Exercise Prices	$ 0.99
Number Outstanding	536,000
Weighted Average Exercise Price, options outstanding	$ 0.6
Weighted Average Remaining Contractual Life	6 years 9 months 18 days
Number Exercisable	440,313
Weighted Average Exercise Price, options exercisable	$ 0.6
Weighted Average Remaining Contractual Life Options Exercisable	6 years 3 months 18 days
Option 3
Lower Limit of Range of Exercise Prices	$ 1.00
Upper Limit Range of Exercise Prices	$ 1.50
Number Outstanding	856,000
Weighted Average Exercise Price, options outstanding	$ 1
Weighted Average Remaining Contractual Life	4 years
Number Exercisable	765,167
Weighted Average Exercise Price, options exercisable	$ 1
Weighted Average Remaining Contractual Life Options Exercisable	3 years 6 months
Total Options
Lower Limit of Range of Exercise Prices	$ 0.50
Upper Limit Range of Exercise Prices	$ 1.50
Number Outstanding	1,605,750
Weighted Average Exercise Price, options outstanding	$ 0.80
Weighted Average Remaining Contractual Life	5 years 7 months 24 days
Number Exercisable	1,374,231
Weighted Average Exercise Price, options exercisable	$ 0.81
Weighted Average Remaining Contractual Life Options Exercisable	5 years 1 month 6 days